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Unprecedented staining of polar lipids
by a luminescent rhenium complex revealed
by FTIR microspectroscopy in adipocytes†
C. A. Bader,a E. A. Carter,b A. Safitri,b P. V. Simpson,c P. Wright,c S. Stagni,d
M. Massi,c P. A. Lay,b D. A. Brooksa and S. E. Plush*a
Fourier transform infrared (FTIR) microspectroscopy and confocal
imaging have been used to demonstrate that the neutral rhenium(I)
tricarbonyl 1,10-phenanthroline complex bound to 4-cyanophenyl-
tetrazolate as the ancillary ligand is able to localise in regions with
high concentrations of polar lipids such as phosphatidylethanolamine
(PE), sphingomyelin, sphingosphine and lysophosphatidic acid (LPA)
in mammalian adipocytes.
Live cell fluorescent imaging provides a valuable tool for the
visualisation of cellular structure and function. One key aspect
of this research area is the design of luminescent molecules,
either organic fluorophores or phosphorescent metal complexes
(each of which possess unique advantages and disadvantages),1–7
that are able to target specific organelles in live cells or specific
analytes of metabolic relevance. While significant advances have
been reported in biological targeting, the specific staining of
lipids (excluding those belonging to membrane layers) in live
cells is an undoubtedly underdeveloped area. Lipids are critical
for membrane structure, to compartmentalise cellular function,
to orchestrate structural events at the membrane interface and to
mediate signalling, but they also have a critical role in metabolic
processes.8 Lipid distribution, degradation, homeostasis and
metabolism have direct significance for major diseases, such
as inflammation, diabetes, cancer, obesity, and heart disease.9
The availability of a diverse family of lipid markers, especially for
visualising lipid orientated process in real time,10 therefore
represents an unmet need in live cell imaging.
Advances in mass spectrometry have allowed high-sensitivity and
high throughput lipid analysis for the study of lipid composition.11
However, the compositional analysis of lipids by electrospray
mass spectrometry relies heavily on the ability to separate cellular
components, which limits the biological relevance of the informa-
tion obtained when using this technology. For example, the
analysis of lipids found in lipid droplet organelles requires
separation of the phospholipid membrane from the hydro-
phobic core and from other cellular components.12,13 Fluores-
cent dyes, such as Oil Red O, Nile Red, Fillipin III, BODIPY and
LipidTox, are also commonly used for the imaging of lipid
biology.14–16 However, the need for cell fixation for effective
staining with Oil Red O, Nile Red, and Fillipin III results in lipid
depletion.17 BODIPY has shown promise for live cell imaging of
lipids. However, dual imaging can be difficult with emission
potential in the red excitation channel as well as its expected
green excitation.18 BODIPY and derivatives thereof also have a
small Stokes-shift, which can lead to self-quenching and can be
modestly cytotoxic.19 LipidTOX is amenable to live cell imaging,
however, it is prone to photo-bleaching and suffers from low
staining efficiency.20 Furthermore, the interaction of these dyes
with lipids is non-specific by nature (e.g., Fillipin III has a higher
specificity for gangliosides (GM1) in contrast to cholesterol;21
emission from Nile Red is dependent on hydrophobicity22),
with the vast majority localising with neutral lipids or phos-
pholipids. Consequently, there is a defined need for the develop-
ment of new molecular probes that exclusively enable live cell
imaging of polar lipids, particularly in conjunction with other
biomarkers.23
We have recently reported the first example of a luminescent
metal complex capable of staining lipid droplets in live Drosophila
tissue and live adipocytes.24 This species is composed of
the neutral Re(I) tricarbonyl 40-cyanophenyltetrazolato complex,
herein designated as ReZolve-L1t (Fig. 1A).‡ The staining of
lipid droplets in live cells is significant as cellular dysfunction
involving lipid droplets is increasingly being linked to major
diseases.25,26 Lipid droplets are intracellular organelles that
have important functions in membrane formation, cellular and lipid
homeostasis (storage), metabolism (hydrolysis), and trafficking
(signalling and transport).27,28
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The observed staining of lipid droplets by ReZolve-L1t (Fig. 1B)
suggests that this metal complex has an affinity for one of the many
lipid families found within lipid droplets. It is classically accepted
that the lipid droplet cores are enriched in neutral lipids, like
triacylglycerides and sterol esters for energy storage and the outer
limiting membrane is a lipid monolayer mainly composed of polar
lipids that can include unesterified cholesterol, sphingomyelin
and phosphatidylethanolamine.29,30 The polar lipids in the outer
membrane of the lipid droplet are integrally involved in lipid
droplet dynamics, intracellular signalling, and lipid compart-
mentalisation, as well as lipid sequestration and trafficking.31,32
However, the localisation of lipids, especially polar lipids, in the
lipid droplet structure has yet to be fully defined.33–35 Therefore,
it is vital that the ‘selectivity’ of ReZolve-L1t for these various
lipid classes be defined.
Interestingly, ReZolve-L1t was found to also be distributed
to other regions of cells (Fig. 1B). A comparison of staining
patterns of ReZolve-L1t using Fillipin III as a co-stain or Oil
Red O (reported in Bader et al.24 and reproduced as Fig. S1 in
ESI†) suggests that ReZolve-L1t may have an affinity for lipids
distinct to that stained by either Fillipin III (cholesterol and
GM1) or Oil Red O (neutral lipids). As there is a high demand
for stains that are able to selectively discriminate polar from
neutral lipids, the lipid ‘specificity’ of ReZolve-L1t warranted
further investigation.
Herein we demonstrate by means of IR microspectroscopy
and confocal imaging36–38 the potential of this unique rhenium
complex to localise with polar lipids in cells. Our results high-
light the first example of a marker that is able to preferentially
localise in areas with high polar lipid concentration, thus
offering a novel biological tool for live cell imaging of lipids.
The FTIR spectrum of solid ReZolve-L1t (Fig. 1A) is dominated
by the strong CRO stretching bands centred at B2027 cm1 and
the doublet 1915/1893 cm1, characteristic of facial tricarbonyl
complexes.39 This is a spectral region where vibrational modes due
to biochemical components are conveniently negligible.40 There is
a range of additional bands for the complex in the region between
1800–600 cm1 and, while these overlap with signals from
cellular components, their relative intensities compared with
those of the CRO bands are such that they have not been used
in the spatial analysis of the complex.
To facilitate the imaging of lipid droplets (where ReZolve-L1t
has the highest intensity staining pattern), a mammalian adipocyte
3T3-L1 cell line was chosen, as these cells have large (up to 150 mm)
lipid droplets when compared to other mammalian cells
(0.1–2 mm).41 To prepare the sample for FTIR analysis, the 3T3-L1
cells were grown on a silicon nitride substrate,38 then rapidly fixed
using cold methanol and air dried38,42 before being incubated with
ReZolve-L1t (10 mM). Importantly, direct growth of the cells on
the silicon nitride substrate, followed by rapid cold MeOH
fixation eliminates biochemical changes that can be induced
by removing adherent cells from cell culture by trypsin, so cells
grow with normal morphology.27 The cells prepared in this
manner also retain the lipid droplets observed under optical
microscopy and enable diverse biospectroscopic studies on
adipocytes with minimal introduction of sampling artifacts.38,43
A bright field image of an adipocyte following incubation with
ReZolve-L1t is shown in Fig. 2A and depicts large characteristic
lipid droplets. IR images generated by calculating the area under
the protein amide I band (1690–1600 cm1), the lipid ester
CQO band (1712–1775 cm1) and the ReZolve-L1t CRO band
(1942–1910 cm1) from this cell are shown in Fig. 2B–D,
Fig. 1 (A) The structure of ReZolve-L1t, which is a neutral fac-[Re(CO)3(phen)(L)], where phen is 1,10-phenanthroline and L is 5-(40-cyanophenyl)tetrazolate
and FTIR spectrum of ReZolve-L1t, with carbonyl ligand bands highlighted; (B) the bio-distribution of ReZolve-L1t in live adipocytes.
Fig. 2 (A) Bright-field image of an adipocyte incubated overnight with
ReZolve-L1t; (B) FTIR image of amide I band; (C) IR image of the lipid ester
n(CQO) band; (D) IR image of ReZolve-L1t CRO band. Designations
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respectively (see ESI,† Fig. S2 for a control cell). The FTIR image
of the lipid ester, Fig. 2C, shows the highest integrated area
coincides with the largest lipid droplet in the bright-field image
Fig. 2A. In addition, a comparison of the highest integrated
intensities from the amide I protein map against the n(CQO)
lipid map showed that there was an area of high protein content
adjacent to the lipid droplet location. This was assigned to the
nucleus because of the high histone protein concentration in
chromatin and is in close proximity to the major lipid droplet.
Lipid droplets and nuclear proteins are often found in close
proximity during the nascent formation of lipid droplets as the
endoplasmic reticulum is an organelle for lipid synthesis.34,41
ReZolve-L1t was detected throughout the cell, which was in
agreement with the localisation of lipids and confocal microscopy
(Fig. 1B). Increased intensities of the bands due to ReZolve-L1t
were observed in regions of high lipid content with some overlap
in the area where lipids and high protein content were in close
proximity, Fig. 2D. IR spectra were then extracted from two
regions within the cell and averaged (Fig. 3; see ESI,† Fig. S3 for
spectra from each region with correlating 2nd derivative analysis).
These regions were selected based on the ReZolve-L1t IR map
shown in Fig. 2D in combination with confocal and epifluores-
cence images of both fixed and live adipocytes (Fig. 1B),24 which
showed the highest accumulation of ReZolve-L1t in these
regions. In both extracted regions the relative absorbance from
the ReZolve-L1t n(CRO) bands was relatively low in comparison
with the other cellular functional groups. This is not unexpected
as the cells were incubated with the same concentration of
ReZolve-L1t that is used in optical imaging experiments to
ensure the same bio-distribution was obtained. Both extracted
spectral averages show intense n(CH) and n(CQO) lipid bands
that can be attributed to high lipid concentration, in comparison
to the smaller contribution from the n(CQO) and n(NH) protein
bands. This relationship suggests that the spectra were extracted
from the lipid droplet (hydrophobic core and membrane) and
not the nuclei or cytoplasmic regions. As expected from the
integrated intensities image shown in Fig. 2D, the spectra
extracted from the area surrounding the lipid droplet marked
Y in Fig. 2D (spectra shown in Fig. 3), including the lipid
droplet membrane, had the highest relative ratio of absorbance
attributed to ReZolve-L1t when compared to known cellular
functional groups. While the spectrum extracted from the region
marked X in Fig. 2D (spectra shown in Fig. 3), inside the centre
of the lipid droplet, showed only a relatively small concentration
of ReZolve-L1t in comparison to cellular functional groups. This
suggested that ReZolve-L1t may be localising in higher concen-
tration with lipids found in the lipid droplet membrane rather
than the neutral lipids (e.g., triglycerides).
To investigate if ReZolve-L1t localises with specific lipids
the spectra from the extracted regions in Fig. 3 were compared
with spectra obtained from pure lipids. A large number of lipid
structures are known to reside in cells, hence, a representative
series of lipids from each of the main lipid families were
chosen for analysis (see ESI,† Fig. S4 for reference IR spectra;
see ESI,† Fig. S5 for peak assignments). Peaks were assigned for
the extracted regions X and Y from second derivative spectra
which allowed for the comparison of bands in the CH stretching
region (3000–2700 cm1) and the lipid references, see Fig. 4.
Fig. 4 shows that the greatest correlation between the spectra
extracted from high probe concentration (region Y) is with polar
lipids. The bands at 2956, 2921, and 2848 cm1 in the spectrum
from region Y are coincident with the bands in the spectra
collected from phosphatidylcholine, phosphatidylethanolamine,
sphingomyelin, sphingosine and lysophosphatidic acid.
There was significantly less correlation with the non-polar
lipids, such as cholesterol esters and triglycerides with the
spectra from region Y. As expected the spectra extracted from
region X showed high peak correlation with triglycerides and
Fig. 3 Average IR spectrum collected from region Y in Fig. 2D (blue)
overlaid with average IR spectrum taken from region X in Fig. 2D (purple).
Fig. 4 Comparison of the FTIR spectra from the CH stretching region
(2750–3020 cm1) extracted from region X and region Y (Fig. 2D) with
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cholesterol acetate (2957, 2928 and 2858 cm1). This suggests
that ReZolve-L1t mainly localised to areas directly adjacent to
the hydrophobic core of the lipid droplet, corresponding to the
limiting membrane. Moreover this indicates that ReZolve-L1t
is predominantly staining polar lipids and not neutral lipids
in contrast to Oil Red O, Nile Red, BODIPY or LipidTOX
(or derivatives thereof). Interestingly, the spectra extracted from
region X did still show overlap with some of the polar lipids,
albeit to a much smaller and less confident extent. It can be
expected that the signal from the lipids will be more intense on
the edges of the droplets as IR light is passed through many
layers on the side (i.e. region Y) as opposed to only two layers at
the top and bottom of the lipid droplet when the spectra are
extracted from the middle (i.e. region X). Alternatively, there
may be a more heterogeneous distribution of polar lipids in
lipid droplets than is classically accepted. The latter correlates
more with confocal microscopy Z-stack analysis which shows
that while ReZolve-L1t staining can be detected throughout the
lipid droplet, it is more intense at the edges of the lipid droplet.
ReZolve-L1t, therefore, provides new and extremely important
biochemical information that has not been obtained previously
with staining and fluorescence microscopies. Future work will
explore how the distribution of different lipids influences the
localisation of ReZolve-L1t and which other lipids might directly
interact with this molecular probe during live cell imaging.
Current commercially available imaging reagents for the live
cell imaging of polar lipids are mainly based on lipid analogues
conjugated to fluorescent tags, such as BODIPY or pyrene.44–47
Although these have assisted the investigation of lipid trafficking
in cells, it is unclear if these analogue species interact with other
cellular structures in the same way as their endogenous counter-
parts.45 Issues with photobleaching and toxicity can also perturb
time-resolved imaging using these reagents.19,45 Alternatively
live-cell imaging of lipids can be achieved by fluorescently tagged
proteins with lipid specific binding domains, which overcomes
the issue of detecting endogenous lipids. However limited
availability of specific proteins for this application combined
with time consuming and costly transfection protocols reduces
applicability.48 To the best of our knowledge, ReZolve-L1t is
the first example of a live cell compatible molecular probe that
localises to areas of high endogenous polar lipid concentration
in preference to non-polar lipids. Furthermore, ReZolve-L1t
has low toxicity,24 can be used in conjunction with other dyes,
shows no to minimal photo-bleaching and has a high staining
efficiency which are some of the drawbacks associated with
other lipid dyes.19,20
Conclusions
We have provided FTIR imaging evidence that ReZolve-L1t
localises to the lipid droplet region of adipocytes, which confirmed
conclusions drawn from fluorescence confocal microscopy imaging.
We ascertained that this molecular probe does not predominantly
localise with neutral lipids, such as triglycerides, but may be more
closely aligned with polar lipids such as phosphatidylcholine,
phosphatidylethanolamine, sphingomyelin, sphingosine and
lysophosphatidic acid which are present in higher concentrations
in lipid droplet membranes. This provided strong evidence that
ReZolve-L1t has an affinity for polar lipids and the unprecedented
potential to image these lipids in live cells.
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